Sponsored by:

Molecular Imaging: Page 300

SNM links repeat imaging to CARE bill
By AuntMinnie.com staff writers
The Society of Nuclear Medicine (SNM) said that taking steps to reduce the number of repeated nuclear and molecular imaging procedures -- such as by requiring technologist licensure -- could save an estimated $1.32 billion in Medicare spending over the next 10 years.
April 24, 2012
AAN: DaTscan SPECT tracer changes Parkinson's treatment
By Rosemary Frei
Results from a randomized clinical trial being presented at this week's American Academy of Neurology (AAN) meeting suggest that the SPECT radiopharmaceutical DaTscan can help clinicians distinguish between tremors due to Parkinson's disease and nonparkinsonian essential tremor, expediting appropriate treatment.
April 23, 2012
Canadian grant funds cancer imaging research
By AuntMinnie.com staff writers
The Ontario Institute for Cancer Research has given a four-year grant valued at more than $2.9 million Canadian ($2.93 million U.S.) to the Centre for Probe Development and Commercialization.
April 23, 2012
ASNC joins MedAxiom to boost educational reach
By AuntMinnie.com staff writers
The American Society of Nuclear Cardiology (ASNC) is joining forces with cardiology practice services provider MedAxiom to expand the business and educational resources available to the cardiology and nuclear cardiology communities, the organizations said in a statement.
April 19, 2012
GE, Swedish firm collaborate on radiotracer program
By AuntMinnie.com staff writers
GE Healthcare and Swedish venture capital firm NXT2B have signed a joint financing agreement to develop a microscale radiotracer infrastructure that includes a cyclotron and PET tracer production.
April 18, 2012
FTC approves Cardinal nuclear pharmacy asset sale
By AuntMinnie.com staff writers
The Federal Trade Commission (FTC) said it has approved Cardinal Health's application to sell nuclear pharmacy assets to Patient Care Infusion.
April 18, 2012
GE gets FDA nod for Q.Freeze PET/CT software
By AuntMinnie.com staff writers
GE Healthcare has received U.S. Food and Drug Administration clearance for its Q.Freeze PET/CT quantitative imaging software.
April 17, 2012
Bayer to sell PET tracer portfolio to Indian firm
By AuntMinnie.com staff writers
Bayer Pharma is selling its portfolio of molecular imaging agents, including a PET tracer designed to detect early signs of Alzheimer's disease, to Indian healthcare conglomerate Piramal Healthcare.
April 15, 2012
Invivo Molecular buys Siemens mobile PET/CT
By AuntMinnie.com staff writers
Mobile PET/CT imaging services provider Invivo Molecular Imaging said it has purchased a mobile configuration of Siemens Healthcare's Biograph 16 TruePoint PET/CT scanner.
April 12, 2012
GE touts early flutemetamol results
By AuntMinnie.com staff writers
GE Healthcare is touting the preliminary results of two phase 3 clinical studies for its investigational PET amyloid imaging agent, flutemetamol, to detect beta amyloid in the brain.
April 10, 2012
Alzheimer's Assn. has concerns about Amyvid
By AuntMinnie.com staff writers
While the Alzheimer's Association supports the U.S. Food and Drug Administration's (FDA) recent clearance of Eli Lilly's Amyvid (florbetapir) radiopharmaceutical to view amyloid plaque in the brain, the organization is calling the use of the PET imaging agent a "double-edged sword."
April 10, 2012
Siemens debuts syngo.PET for Amyvid
By AuntMinnie.com staff writers
Siemens Healthcare is wasting no time in taking advantage of its existing partnership with Eli Lilly and its Amyvid (florbetapir F-18 injection) PET imaging agent.
April 9, 2012
Previous Page
Page 300 of 611
Next Page